Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Pharmaceutical Treatments for Typical CKD Comorbidities | Synapse

February 12, 2026Open Access

Pharmaceutical Treatments for Typical CKD Comorbidities

Key Points

The aim is to explore pharmaceutical treatments for managing comorbidities associated with chronic kidney disease.
Review of existing literature on CKD and its comorbidities
Analysis of pharmaceutical interventions
Evaluation of morbidity and mortality outcomes
Identified key pharmaceutical treatments for CKD-related comorbidities
Highlighted the relationship between treatment adherence and patient outcomes
Demonstrated potential for reduced healthcare costs through effective management

Abstract

Chronic kidney disease (CKD) represents a major global health challenge due to its high prevalence in the general population and its substantial impact in terms of morbidity, mortality, and healthcare costs ...

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Lauro et al. (Tue,) studied this question.

synapsesocial.com/papers/698d6df45be6419ac0d534ae https://doi.org/https://doi.org/10.3390/biomedicines14020401

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Endothelial Dysfunction and Therapeutic Advances in Chronic Kidney Disease2025 · 7 citations
2KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease2024 · 7,339 citations
3Epidemiology of chronic kidney disease: an update 20222022 · 2,767 citations
4A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease2019 · 303 citations
5Innate immune cells in acute and chronic kidney disease2025 · 34 citations